GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hodayat Haaretz Ltd (XTAE:HDHA-M) » Definitions » EV-to-Revenue

Hodayat Haaretz (XTAE:HDHA-M) EV-to-Revenue : (As of Jul. 19, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Hodayat Haaretz EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hodayat Haaretz's enterprise value is ₪6.79 Mil. Hodayat Haaretz does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Hodayat Haaretz's EV-to-Revenue at this moment.

The historical rank and industry rank for Hodayat Haaretz's EV-to-Revenue or its related term are showing as below:

XTAE:HDHA-M's EV-to-Revenue is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.285
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-07-19), Hodayat Haaretz's stock price is ₪22.80. Hodayat Haaretz does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Hodayat Haaretz's PS Ratio at this moment.


Hodayat Haaretz EV-to-Revenue Historical Data

The historical data trend for Hodayat Haaretz's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hodayat Haaretz EV-to-Revenue Chart

Hodayat Haaretz Annual Data
Trend
EV-to-Revenue

Hodayat Haaretz Semi-Annual Data
EV-to-Revenue

Competitive Comparison of Hodayat Haaretz's EV-to-Revenue

For the Medical Devices subindustry, Hodayat Haaretz's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hodayat Haaretz's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hodayat Haaretz's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hodayat Haaretz's EV-to-Revenue falls into.


;
;

Hodayat Haaretz EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hodayat Haaretz's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6.792/
=


Hodayat Haaretz  (XTAE:HDHA-M) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hodayat Haaretz's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=22.80/
=


Hodayat Haaretz EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hodayat Haaretz's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hodayat Haaretz Business Description

Traded in Other Exchanges
N/A
Address
7 Haarad Street, Tel-Aviv, ISR, 6971060
Hodayat Haaretz Ltd formerly Envizion Medical Ltd is a medical device company. It is focused on improving patient outcomes across the continuum of care, encompassing the development of advanced, personalized navigation technology for feeding tubes, responding to the challenges of the ever changing healthcare environment, while continuously focusing on the customer.

Hodayat Haaretz Headlines

No Headlines